Welcome to our dedicated page for Castor Maritime SEC filings (Ticker: CTRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing hundreds of pages on vessel purchases, charter coverage, and bunker-fuel clauses can overwhelm even seasoned analysts. Castor Maritime’s SEC disclosures pack dense maritime jargon, fleet tables, and shifting freight-rate assumptions into every 10-K and 10-Q. If you’ve ever asked, “How do I track Castor Maritime insider trading Form 4 transactions or read an 8-K material event explained without drowning in acronyms?”—this page is built for you.
Stock Titan’s AI turns complexity into clarity. Our engine highlights where the annual Castor Maritime annual report 10-K simplified reveals vessel fair-value adjustments, spots debt covenant red-flags in the Castor Maritime quarterly earnings report 10-Q filing, and surfaces every Castor Maritime executive stock transactions Form 4 within minutes of hitting EDGAR. Real-time alerts make sure you never miss a Castor Maritime Form 4 insider transactions real-time update or a sudden charter-rate disclosure buried deep in an exhibit.
Wondering which filings answer which questions? Here’s a quick guide:
- 10-K: Fleet breakdown, impairment tests, long-term charter mix—Castor Maritime SEC filings explained simply.
- 10-Q: Quarter-over-quarter freight-rate sensitivity, liquidity runway—ideal for Castor Maritime earnings report filing analysis.
- 8-K: Immediate vessel acquisitions or loan refinancings—Castor Maritime 8-K material events explained in plain English.
- Form 4: Track captain and CEO share moves via Castor Maritime insider trading Form 4 transactions.
- DEF 14A: Dive into Castor Maritime proxy statement executive compensation without parsing footnotes.
Whether you need charter-rate context before the market opens or want to understand debt amortization schedules, our AI-powered summaries, expert annotations, and real-time feeds let you act on facts, not page counts. Start understanding Castor Maritime SEC documents with AI—and make shipping disclosures work for you.
Allarity Therapeutics, Inc. (Nasdaq: ALLR) filed a Form 8-K covering executive management changes effective at the end of Q2-25.
- CFO Resignation: Alexander Epshinsky resigned on 30 Jun 2025. The company states the departure was not related to disagreements over operations, accounting or disclosure.
- CFO Appointment: Effective 1 Jul 2025, Jeffrey S. Ervin, age 48, was named part-time Chief Financial Officer. Ervin is an experienced public-company founder/CEO who led IMAC Holdings’ 2019 Nasdaq IPO and currently serves as an independent director of Cingulate, Inc.
- Compensation Terms: Employment Agreement sets a $175,000 annual base salary. If terminated in connection with a Change-of-Control, Ervin will receive six months of salary continuation.
- Governance Disclosures: No family relationships or related-party transactions (>$120k) were identified. Exhibit 10.1 contains the full employment agreement.
The filing is limited to leadership transition matters; it contains no operating or financial performance data. Investors should monitor future filings to assess execution under new financial leadership and any implications for liquidity or strategic direction.
FAQ
What is the current stock price of Castor Maritime (CTRM)?
What is the market cap of Castor Maritime (CTRM)?
What is the primary business of Castor Maritime Inc?
How does the company structure its operations?
Which cargoes are typically transported by Castor Maritime?
How does Castor Maritime manage market fluctuations?
What differentiates Castor Maritime in the competitive maritime industry?
Does Castor Maritime only focus on dry bulk shipping?
How does the company ensure operational efficiency?
What is the significance of fleet diversification for Castor Maritime?
